China Meheco Group Co., Ltd. (SHA:600056)

Market Cap	13.61B -12.4%
Revenue (ttm)	35.02B +0.1%
Net Income	482.86M -20.8%
EPS	0.32 -20.8%
Shares Out	1.50B
PE Ratio	28.19
Forward PE	n/a
Dividend	0.09 (1.04%)
Ex-Dividend Date	n/a

Volume	9,593,536
Open	9.07
Previous Close	9.10
Day's Range	8.97 - 9.16
52-Week Range	8.90 - 12.48
Beta	0.16
Analysts	Buy
Price Target	12.76 (+40.37%)
Earnings Date	Aug 25, 2026

About China Meheco Group

China Meheco Group Co., Ltd. engages in the manufacture, marketing, and trade of pharmaceuticals and medical devices in China and internationally. The company is involved in the planting and sale of Chinese medicinal materials, as well as the provision of related technical and warehousing services. Its drug products cover therapeutic fields, such as anti-infection, cardiovascular, hormones and endocrine regulation, respiratory and digestive systems, nutritional supplements, antipyretic analgesics, and other therapeutic areas as well as Chinese ...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1983
• Employees: 7,949
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600056

Financial Performance

In 2025, China Meheco Group's revenue was 35.36 billion, an increase of 0.34% compared to the previous year's 35.24 billion. Earnings were 473.23 million, a decrease of -18.77%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 18, 2026

Data Sources Report a data error